Biomedical Engineering Reference
In-Depth Information
[12]
Midander K, P Cronholm, HL Karlsson, K Elihn, L Möller, C Leygraf and IO Wallinder
(2009). Surface characteristics, copper release, and toxicity of nano- and micrometer-sized
copper and copper(II) oxide particles: a cross-disciplinary study. Small 5: 389-399.
[13]
Chen Z, H Meng, G Xing, C Chen, Y Zhao, G Jia, T Wang, H Yuan, C Ye and F Zhao (2006).
Acute toxicological effects of copper nanoparticles in vivo. Toxicology Letters 163: 109-120.
[14]
Monteiro-Riviere NA and AO Inman (2006). Challenges for assessing carbon nanomaterial toxicity
to the skin. Carbon 44: 1070-1078.
[15]
Bakand S, A Hayes and F Dechsakulthorn (2012). Nanoparticles: a review of particle toxicology
following inhalation exposure. Inhalation Toxicology 24: 125-135.
[16]
Buzea C, II Pacheco and K Robbie (2007). Nanomaterials and nanoparticles: sources and toxicity.
Biointerphases 2: MR17-MR71.
[17]
Schrand AM, JJ Schlager, L Dai and SM Hussain (2010). Preparation of cells for assessing
ultrastructural localization of nanoparticles with transmission electron microscopy. Nature
Protocols 5: 744-757.
[18]
Na HB, IC Song and T Hyeon (2009). Inorganic nanoparticles for MRI contrast agents.
Advanced Materials 21: 2133-2148.
[19]
Sharma P, S Brown, G Walter, S Santra and B Moudgil (2006). Nanoparticles for bioimaging.
Advances in Colloid and Interface Science 123-126: 471-485.
[20]
Sohaebuddin SK, PT Thevenot, D Baker, JW Eaton and L Tang (2010). Nanomaterial cytotoxicity
is composition, size, and cell type dependent. Particle and Fibre Toxicology 7: 22.
[21]
Smith SM, MB Wunder, DA Norris and YG Shellman (2011). A simple protocol for using a
LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same
time. PloS One 6: e26908.
[22]
Kim JA, C Aberg, A Salvati and KA Dawson (2012). Role of cell cycle on the cellular uptake
and dilution of nanoparticles in a cell population. Nature Nanotechnology 7: 62-68.
[23]
Walsh GM, G Dewson, AJ Wardlaw, F Levi-Schaffer and R Moqbel (1998). A comparative
study of different methods for the assessment of apoptosis and necrosis in human eosinophils.
Journal of Immunological Methods 217: 153-163.
[24]
Chan W-H and N-H Shiao (2008). Cytotoxic effect of CdSe quantum dots on mouse embryonic
development. Acta Pharmacologica Sinica 29: 259-266.
[25]
Elmore S (2007). Apoptosis: a review of programmed cell death. Toxicologic Pathology 35:
495-516.
[26]
Lao F, L Chen, W Li, C Ge, Y Qu, Q Sun, Y Zhao, D Han and C Chen (2009). Fullerene
nanoparticles selectively enter oxidation-damaged cerebral microvessel endothelial cells and
inhibit jnk-related apoptosis. ACS Nano 3: 3358-3368.
[27]
Mahmoudi M, H Hofmann, B Rothen-Rutishauser and A Petri-Fink (2011). Assessing the
in
vitro
and
in vivo
toxicity of superparamagnetic iron oxide nanoparticles. Chemical Reviews 112:
2323-2338.
[28]
Franken NAP, HM Rodermond, J Stap, J Haveman and C van Bree (2006). Clonogenic assay of
cells
in vitro
. Nature Protocols 1: 2315-2319.
[29]
Baudino TA, C McKay, H Pendeville-Samain, JA Nilsson, KH Maclean, EL White, AC Davis,
JN Ihle and JL Cleveland (2002). c-Myc is essential for vasculogenesis and angiogenesis during
development and tumor progression. Genes and Development 16: 2530-2543.
[30]
Hsin Y-H, C-F Chen, S Huang, T-S Shih, P-S Lai and PJ Chueh (2008). The apoptotic effect of
nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial
pathway in NIH3T3 cells. Toxicology Letters 179: 130-139.
[31]
Chambers JW and PV LoGrasso (2011). Mitochondrial c-Jun N-terminal kinase (JNK) sig-
naling initiates physiological changes resulting in amplification of reactive oxygen species gen-
eration. Journal of Biological Chemistry 286: 16052-16062.
[32]
Shen HM and ZG Liu (2006). JNK signaling pathway is a key modulator in cell death mediated
by reactive oxygen and nitrogen species. Free Radical Biology and Medicine 40: 928-939.
[33]
Fridman JS and SW Lowe (2003). Control of apoptosis by p53. Oncogene 22: 9030-9040.
[34]
Vazquez A, EE Bond, AJ Levine and GL Bond (2008). The genetics of the p53 pathway, apoptosis
and cancer therapy. Nat Rev Drug Discov 7: 979-987.
